The role of all-trans-retinoic acid (ATRA) treatment in newly-diagnosed acute promyelocytic leukemia patients aged >60 years
Open Access
- 1 December 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (12) , 1273-1275
- https://doi.org/10.1023/a:1008272817839
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupBlood, 1993
- Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1993
- Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaThe Lancet, 1992
- ACUTE PROMYELOCYTIC LEUKAEMIABritish Journal of Haematology, 1992
- Epidemiology of acute promyelocytic leukemia in ItalyAnnals of Oncology, 1991
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Acute promyelocytic leukemia.Therapy results and prognostic factorsCancer, 1988